Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Grainger sees strong lease-up for latest Canning Town build

(Sharecast News) - Residential landlord Grainger has announced that its new Seraphina Apartments asset in Canning Town has experienced stronger-than-expected demand, with 50% of units leased out in under a month. The lease-up performance, which the company said was well ahead of expectations, is a "fantastic result and a clear demonstration of the demand for our high-quality rental homes", according to chief executive Helen Gordon.

Seraphina Apartments, which was only completed earlier this summer, is the third and final phase of Grainger's Fortune Dock cluster in Canning Town.

Together with Argo Apartments and Nautilus Apartments, Grainger owns 412 homes across Fortune Dock and has invested £152m in total in Canning Town.

"[The lease-up performance] reflects the strength of our operational platform and the benefits of our cluster strategy, which enables us to build thriving communities, deliver operational efficiencies and deepen our understanding of local customer needs," Gordon said.

"Seraphina Apartments is already proving to be a great success, and we look forward to welcoming more residents in the weeks ahead."

Grainger, which officially converted to a real estate investment trust earlier this week, said it "remains confident in its strong outlook and its focused strategy to deliver long-term, compounding returns and progressive dividends for its shareholders".

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.